Cilostazol Tablets Recalled for Potential Labeling Mixup with Dutasteride
Aidapak Services is recalling Cilostazol 100 mg tablets due to a labeling mixup where they may be mislabeled as Dutasteride 0.5 mg capsules.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, which typically indicates a situation where use of the product may cause temporary or medically reversible health consequences. The hazard is a labeling mixup, which is a significant risk but does not involve a structural defect or reported fatalities.
Plain-English summary
Aidapak Services, LLC is recalling Cilostazol Tablet, 100 mg, Rx only, NDC 60505252201. The recall is due to a labeling mixup where the product may be potentially mislabeled as Dutasteride, Capsule, 0.5 mg, NDC 00173071204.
The affected product is identified by Pedigree AD65475_4 and an expiration date of 5/28/2014. The repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Consumers and healthcare providers should check their inventory for this specific NDC and pedigree. If the product is found, it should be returned to the distributor or disposed of according to local regulations. Patients should consult their healthcare provider if they have questions regarding their medication.
The recalled product
- Product
- CILOSTAZOL Tablet, 100 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 60505252201
- Manufacturer
- Aidapak Services, LLC
- Category
- Drug — Prescription Medication
- Hazard
- Affected units
- 60
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- CILOSTAZOL
- Tablet
- 100 mg has the following code Pedigree: AD65475_4
- EXP: 5/28/2014.
Distribution
Part of a larger recall action
This product is one of 273 recalled by Aidapak Services, LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 273 products in this recall →Related recalls
Same manufacturer · Aidapak Services, LLC
See all →- ModerateAidapak Recalls Sennosides Tablets Due to Potential Labeling Errors
FDA (Drugs) · 2014-01-29
- ModerateLevothyroxine Sodium Tablets Recalled for Potential Labeling Mixup
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Mislabeled Pantoprazole Sodium DR Tablets
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Nifedipine ER Tablets Due to Potential Label Mixup
FDA (Drugs) · 2014-01-29
- ModerateSimvastatin Tablets Recalled for Potential Labeling Error
FDA (Drugs) · 2014-01-29
Same hazard · mis labeling
See all →- SevereWhite Vein Advanced Alkaloids Chewable Tablets Recall for Excess Active Ingredient
FDA (Food) · 2026-10-14
- SevereBetter Bakehouse Recalls Donutful Chocolate Dipped Vanilla Cake Donuts for Undeclared Milk
FDA (Food) · 2026-10-14
- HighFreshPoint Recalls Cranberry Chicken Salad Wedges for Undeclared Egg Allergen
FDA (Food) · 2026-10-14
- HighJ K Patisserie & Bakery LLC Recalls Croissants for Undeclared Egg
FDA (Food) · 2026-10-14
- ModerateHalyard Laparoscopy Comprehensive Pack II Recalled for Latex Content
FDA (Devices) · 2026-10-14
Similar recalls
- ModerateCilostazol Tablets Recalled for Potential Labeling Error
FDA (Drugs) · 2014-01-29
- ModerateCilostazol Tablets Recalled for Potential Label Mixup with Calcium Acetate
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Dutasteride Capsules Due to Potential Labeling Mixup
FDA (Drugs) · 2014-01-29
- ModerateValsartan 320 mg Tablets Recalled for Potential Labeling Error
FDA (Drugs) · 2014-01-29
- SevereDutasteride Capsules Recalled for Potential Labeling Mixup
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls CapsuleTOPRIL Tablets Due to Potential Label Mixup
FDA (Drugs) · 2014-01-29